Roche Hldg AG GEN

RHO5 
(XETRA) 
 
245.20
Updated 27/06/2019
Change % -1.05% Stock price decreasing
Change 0.00 Stock price unchanged
Volume 0
High 0
Low 0
Open 245.15
ISIN CH0012032048
Prev close 247.80
# of shares 702.56M
Market cap 172,268M EUR
Intraday

Market closed
Roche Hldg AG GEN
Market is closed, opens at 08:00
 
Price development Latest 1 week 1 month 3 months 6 months 1 year
 
  245.20 0.0% Stock price unchanged 0.0% Stock price unchanged 1.8% Stock price increasing 0.6% Stock price increasing 16.1% Stock price increasing
Powered by TradingView

Related

Latest 1 week 1 month 3 months 6 months 1 year
YTD
 
Competitors Open
 
Abbott Laboratories 81.93 -3.4% Stock price decreasing -6.9% Stock price decreasing 6.4% Stock price increasing 6.6% Stock price increasing 23.9% Stock price increasing 13.3% Stock price increasing
 
Bristol-Myers Squibb Company 46.58 -0.9% Stock price decreasing 2.6% Stock price increasing -0.5% Stock price decreasing -8.0% Stock price decreasing -22.3% Stock price decreasing -10.4% Stock price decreasing
 
Eli Lilly and Company 109.51 -0.9% Stock price decreasing 1.6% Stock price increasing -6.2% Stock price decreasing -11.6% Stock price decreasing 3.5% Stock price increasing -5.4% Stock price decreasing
 
Merck & Company Inc (new) 84.94 -0.1% Stock price decreasing 3.9% Stock price increasing 4.6% Stock price increasing 5.7% Stock price increasing 23.0% Stock price increasing 11.2% Stock price increasing
 
Pfizer Inc 34.34 -0.9% Stock price decreasing -19.5% Stock price decreasing -18.1% Stock price decreasing -20.3% Stock price decreasing -19.0% Stock price decreasing -21.3% Stock price decreasing
 
Astrazeneca PLC ORD SHS $0.25 7,313.00 0.8% Stock price increasing 6.8% Stock price increasing 20.1% Stock price increasing 16.3% Stock price increasing 24.2% Stock price increasing 24.5% Stock price increasing
 
Glaxosmithkline PLC ORD 25P 1,691.20 2.0% Stock price increasing 1.3% Stock price increasing 6.9% Stock price increasing 10.2% Stock price increasing 5.5% Stock price increasing 13.4% Stock price increasing
 
Sanofi 76.73 1.0% Stock price increasing 1.8% Stock price increasing 2.1% Stock price increasing 5.5% Stock price increasing 2.7% Stock price increasing 1.4% Stock price increasing
 
Novartis N 87.34 -0.2% Stock price decreasing -4.5% Stock price decreasing 0.1% Stock price increasing 8.3% Stock price increasing 20.1% Stock price increasing 17.6% Stock price increasing

Company profile

Roche is a Swiss biopharmaceutical and diagnostic company. The firm's best-selling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 60% of pharmaceutical sales, and professional diagnostics for more than half of diagnostic-related sales.

Peers

Instruments Last Change  
Abbott Labor.. 81.93 -2.9% Stock price decreasing
Bristol-Myer.. 46.58 -2.7% Stock price decreasing
Eli Lilly an.. 109.51 -1.9% Stock price decreasing
Merck & Comp.. 84.94 -2.1% Stock price decreasing
Pfizer Inc 34.34 -2.1% Stock price decreasing
Astrazeneca .. 7,313.00 -0.2% Stock price decreasing
Glaxosmithkl.. 1,691.20 0.9% Stock price increasing
Sanofi 76.73 -0.4% Stock price decreasing
Novartis N 87.34 -0.5% Stock price decreasing
42,90,84,89,91,38,46,66,58,9

Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
25 August 2019 04:27:47
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190819.1 - EUROWEB4 - 2019-08-25 05:27:47 - 2019-08-25 04:27:47 - 1000 - Website: OKAY